Benefits of a calcium antagonist, nifedipine GITS, in arterial hypertension treatment
Based on the results of international clinical trials, the clinical benefits of a dihydropyridine calcium antagonist, nifedipine GITS (slow-release gastrointestinal therapeutic-system) are discussed. Nifedipine GITS has been demonstrated to reduce cardiovascular morbidity and mortality effectively....
| Published in: | Кардиоваскулярная терапия и профилактика |
|---|---|
| Main Authors: | , |
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2008-12-01
|
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1634 |
| _version_ | 1849507238522126336 |
|---|---|
| author | V. B. Mychka I. E. Chazova |
| author_facet | V. B. Mychka I. E. Chazova |
| author_sort | V. B. Mychka |
| collection | DOAJ |
| container_title | Кардиоваскулярная терапия и профилактика |
| description | Based on the results of international clinical trials, the clinical benefits of a dihydropyridine calcium antagonist, nifedipine GITS (slow-release gastrointestinal therapeutic-system) are discussed. Nifedipine GITS has been demonstrated to reduce cardiovascular morbidity and mortality effectively. The medication is safe and metabolically neutral even when administered as a long-term treatment. |
| format | Article |
| id | doaj-art-5bbefb4f767d4bb29aab3078f4fcfbf0 |
| institution | Directory of Open Access Journals |
| issn | 1728-8800 2619-0125 |
| language | Russian |
| publishDate | 2008-12-01 |
| publisher | «SILICEA-POLIGRAF» LLC |
| record_format | Article |
| spelling | doaj-art-5bbefb4f767d4bb29aab3078f4fcfbf02025-08-20T02:59:54Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252008-12-017656591351Benefits of a calcium antagonist, nifedipine GITS, in arterial hypertension treatmentV. B. Mychka0I. E. Chazova1A.L. Myasnikov Research Institute of Clinical Cardiology, Russian Cardiology Scientific and Clinical Complex. MoscowA.L. Myasnikov Research Institute of Clinical Cardiology, Russian Cardiology Scientific and Clinical Complex. MoscowBased on the results of international clinical trials, the clinical benefits of a dihydropyridine calcium antagonist, nifedipine GITS (slow-release gastrointestinal therapeutic-system) are discussed. Nifedipine GITS has been demonstrated to reduce cardiovascular morbidity and mortality effectively. The medication is safe and metabolically neutral even when administered as a long-term treatment.https://cardiovascular.elpub.ru/jour/article/view/1634cardiovascular diseasecalcium antagonistsnifedipine gitseffectiveness and safety |
| spellingShingle | V. B. Mychka I. E. Chazova Benefits of a calcium antagonist, nifedipine GITS, in arterial hypertension treatment cardiovascular disease calcium antagonists nifedipine gits effectiveness and safety |
| title | Benefits of a calcium antagonist, nifedipine GITS, in arterial hypertension treatment |
| title_full | Benefits of a calcium antagonist, nifedipine GITS, in arterial hypertension treatment |
| title_fullStr | Benefits of a calcium antagonist, nifedipine GITS, in arterial hypertension treatment |
| title_full_unstemmed | Benefits of a calcium antagonist, nifedipine GITS, in arterial hypertension treatment |
| title_short | Benefits of a calcium antagonist, nifedipine GITS, in arterial hypertension treatment |
| title_sort | benefits of a calcium antagonist nifedipine gits in arterial hypertension treatment |
| topic | cardiovascular disease calcium antagonists nifedipine gits effectiveness and safety |
| url | https://cardiovascular.elpub.ru/jour/article/view/1634 |
| work_keys_str_mv | AT vbmychka benefitsofacalciumantagonistnifedipinegitsinarterialhypertensiontreatment AT iechazova benefitsofacalciumantagonistnifedipinegitsinarterialhypertensiontreatment |